'Young blood' anti-ageing mechanism called into question

  title={'Young blood' anti-ageing mechanism called into question},
  author={Sara Reardon},
A protein in the blood of young mice that seemed to rejuvenate older animals may do the opposite. 

Topics from this paper

The Fountain of Youth: A Tale of Parabiosis, Stem Cells, and Rejuvenation
The question about giving whole blood or specific factors in helping rejuvenation is open, as well as the mechanisms of action of these factors, deserving further studies to be translated into the life of (old) human beings.
Anti-Aging Medicine as a Game Changer for Long-Lasting Space Missions
Many studies have highlighted that astronauts involved in long-lasting space missions are at risk of developing pathologies similar to those caused by aging. This finding has led several scholars to
Science, science fiction, and Nick Payne’s Elegy: a conceptual third way
ABSTRACT The depiction of science in theatre has been widely acknowledged and debated, while discussion of science fiction in theatre remains limited. Specifically, plays which draw upon the


Vascular and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic Factors
It is shown that factors found in young blood induce vascular remodeling, culminating in increased neurogenesis and improved olfactory discrimination in aging mice, and that GDF11 alone can improve the cerebral vasculature and enhance Neurogenesis.
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
Treatment of old mice to restore GDF11 to youthful levels recapitulated the effects of parabiosis and reversed age-related hypertrophy, revealing a therapeutic opportunity for cardiac aging.
Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle
It is demonstrated that the circulating protein growth differentiation factor 11 (GDF11) is a rejuvenating factor for skeletal muscle, and systemically regulates muscle aging and may be therapeutically useful for reversing age-related skeletal muscle and stem cell dysfunction.
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.
A GDF11-specific immunoassay is developed and a trend toward increased GDF 11 levels in sera of aged rats and humans is shown and GDF12 could be a target for pharmacologic blockade to treat age-related sarcopenia.